The Nevada Dental Association advocates on behalf of its association members with legislators, regulators, and other partners. Working closely with our association members, and under the guidance and oversight from NDA leadership and member-led councils, the NDA works on a host of oral health issues ranging from scope of practice to accessing care.
The NDA is committed to supporting efforts that ensure Nevada citizens have access to good oral health care. We know that this is a constant challenges and in order of us to be successful, we need your help. Contact the NDA office to learn more about the different ways member dentists can get involved in the legislative process.
Your involvement can be big or small; from writing a letter, to attending a meeting with a legislator; from making a phone call, or to testifying in a legislative committee. Dentists make the best advocates for oral health care issues, so get involved today!
The NDA provides access to all the latest news on legislative issues, tools, templates, and guides. See our Award winning NDA Journal Quarterly Publications and NDA Monthly Newsletters with content provided from our own dentist members in Nevada. Join our Facebook page to receive current information on new benefits! Stay compliant, informed and engaged.
Member Access Page
Removal of DATA Waiver Requirement for Opioid Use Disorder Prescriptions
Notice from Nevada State Board of Pharmacy - On December 29, 2022, Congress signed into law with the Consolidated Appropriations Act of 2023 (the Act), which eliminated the “DATA-Waiver Program.” The Act removes the federal requirement for practitioners obtain a Data-Waiver (X-waiver) to prescribe medications such as buprenorphine, a Schedule III controlled substance, for the treatment of opioid use disorder (OUD). On January 12, 2023, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the immediate elimination of the X-Waiver for prescribing buprenorphine. The elimination of the X-waiver will increase the number of practitioners eligible to prescribe buprenorphine thereby increasing access to buprenorphine for those in need.